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Special Article

Significance of Antinuclear Antibody (ANA) Immunofluorescent
Patterns and Titers in Systemic Lupus Erythematosus Nephritis
Syed Akbar, MD,* Abel I. Tello, MD,t Usana Luvira, MD,* Rollin Heinzerling, PhD,§
Raymond Romanski, MD,I Nathan W. Levin, MD,* and Thomas K.H. Burnham,
MB, BS (London)^

Seventy-three patients with systemic lupus erythematosus (SLE) nephritis were studied for up to eight
years using sequential serologic and renal function tests and renal biopsies. Antinuclear antibody
(ANA) pallerns and titers were classified into two syslems: nonparticulate and particulate. We found a
close relationship between disease activity and changes in titers ofthe nonparticulate peripheral
homogeneous system. These changes predicted imminent flare-up or immunosuppressive induced
remission of nephritis. Patients with the thready ANA pattern (part of the particulate system) as the
main pattern showed a predominant association with membranous glomerulopathy and better renal
function than those without threads. The association ofthe thready pattern with relatively benign
disease suggests that patients with this pattern may represent a benign subset in the spectrum of renal
SLE. (Henry Ford Hosp MedJ 1988:36:121-9)

V

arious nuclear immunofluorescent pattems have been identified by indirect immunofluorescence employing human
spleen imprints as substrate (1,2). Two systems of antinuclear
antibody (ANA) pattems can be identified: nonparticulate and
particulate (Fig 1, Table 1). The nonparticulate pattems consist
of general ANA which is reactive with various different nuclei
and leukocyte-specific ANA (LSANA) reactive only with granulocytic nuclei. The nonparticulate system, both general and
leukocyte-specific, is further subdivided into the shrunken peripheral, peripheral, and homogeneous patterns. The particulate
system, so-called because stained particles can be demonstrated
(3), includes the thready and the speckle-like thready pattems.
The pattems classified as particulate in this study were all ofthe
general ANA class. A relationship between certain ANA patterns and specific connective tissue diseases has been shown
previously (1). Subsequently, the correlation between the different patterns and the clinical manifestafions of systemic lupus
erythematosus (SLE) has been studied (4). Pattems were classified into those of poor, intermediate, or good prognostic significance with reference to the prevalence of renal disease. Patients
with the shrunken peripheral pattem had a poor prognosis in that
at least 60% had clinical renal involvement. In the intermediate
prognostic group, which consisted of the peripheral, thready,
and homogeneous pattems with titers of 160 or greater, approximately one third of the patients had renal disease. The good
prognostic group was comprised of patients with large and small
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speckle-like threads. Only three of 73 SLE patients had large
speckle-like threads as their main pattem. If these latter pattems
were the only ones seen in the face of active disease, the likelihood of renal involvement was very small even in the presence
of titers as high as 10,240 ofthe large speckle-like threads.

Special Note—This work is the culmination ofthe pioneer
studies done by Thomas K.H. Burnham, MB, BS (London), and
coworkers at Henry Ford Hospital over a period of 26 years.
Highlights ofthis work included the discovery of the lupus band
in 1963, now used in the "lupus band test," and the original
finding and determination ofthe clinical significance of several
nuclear immunofluorescent patterns in the connective tissue
disease.
Submitted for publication: June 2, 1988.
Accepted for publication: July I . 1988.
•Division of Nephrology and Hypertension, Henry Ford Hospital.
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tFormerly Division of Nephrology and Hypertension, Henry Ford Hospital. Currently
Bangkok. Thailand.
tFormerly Department of Dermatology. Henry Ford Hospital. Curtendy Incstar Corporation, Stillwater, MN.
IIFormeriy Department of Pathology, Henry Ford Hospital. Curtently Brimley. Ml.
IFormerly Department of Dermatology, Henry Ford Hospital. Curtently Solana Beach
CA.
Address correspondence to Dr Akbar, Department of Internal Medicine. Henry Ford
Hospital, Fairiane Center. 19401 Hubbard Drive, Dearborn, Ml 48126.
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Table 1
Classification of ANA Patterns*
Nonparticulate Patternst
General ANA
Shmnken peripheral
Peripheral
/Titer 160 or greater
Homogeneous
^Titer less than 160
Leukocyle-specific ANA
Shmnken peripheral
Fferipheral
/Titer 640 or greater
Homogeneous
\Titer less than 640
Particulate Patternst

Fig 1—Diagrams of major ANA patterns. A. Peripheral general: a bright outer edge is seen with gradual darkening from
the inner border to the dark center. B. Shrunken peripheral general: nucleus is only about one-third the usual size found with
other patterns and consequently has a shrunken appearance. C.
Homogeneous leukocyte-specific: one granulocytic nucleus is
seen fluorescing intensely while the nongranulocytic nuclei are
negative. D. Homogeneous general: diffuse fluorescence ofthe
whole nucleus is present. E. Threads: irregularly shaped
clumps, threads, and round structures of different sizes illustrate this pattern. F. Large speckle-like threads: note asymmetrically distributed small round and elongated thread-like
structures.

These findings suggested that certain ANA patterns may
serve as immunological markers for different clinical subsets in
the connective tissue diseases. This has been confirmed recentiy
both in lupus erythematosus (LE) and scleroderma. In LE, the
larger speckle-like thready pattem was found to be a marker for
a benign subset (5). These patients have only generalized skin
lesions with or without joint involvement. The large specklelike thready pattem has been found to be closely related to, but
possibly not actually produced by, antibodies to the cellular antigen RO (6). In scleroderma the "tme speckled" ANA pattem
which represents the anticentromere antibody (7,8) is a marker
for a benign subset of scleroderma (9). These patients all had
benign disease, the majority having acrosclerosis without pulmonary, cardiac, or renal involvement. As certain ANA pattems
are therefore markers for relatively broad clinical subsets, we
wished to determine if any ANA patterns could also serve as
immunological markers for narrower clinical subsets such as
different types of renal involvement in pafients with SLE.
Various attempts have been made to correlate other laboratory
data with the activity and severity of lupus nephritis (10). Studies
have shown that circulating DNA-anti-DNA complexes disappear with remission of active SLE (11,12). Patients with IgG containing anti-DNA antibodies have renal disease of greater severity than those with IgM anti-DNA antibodies (13).
We have found that the nonparticulate system is more closely
related to disease activity than is the particulate system. Most
authors have not made such a differentiation which may be why
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Threads
Large speckle-like threads
Small speckle-like threads
Other particulates: significance in SLE so far unknown
Nucleolar and speckles—not seen in SLE
*From References 1 and 4.
tModified from Reference 3.

they failed to recognize a relationship between ANA titers and
disease activity in SLE (14-17). However, we have demonstrated
relationships between the particulate system represented by the
thready ANA pattern and specific histological diagnoses in
patients with SLE nephritis.
In this study we correlated specific ANA patterns and titers
with the clinical activity and severity of SLE as shown by histopathology and evaluation of renal function.

Materials and Methods
Patients
We studied 73 patients with SLE. Sera for ANA determinations were obtained when possible before immunosuppressive
therapy and also 10 minutes after intravenous nitrogen mustard,
when this was used, or 30 minutes after initiation of oral prednisone and/or oral azathioprine therapy and then two and four
weeks later. ANA determinations were repeated if any change
occurred in the clinical status or the therapeutic regimen. Simultaneous determinations were made of anti-DNA and anti-extractable nuclear antigen (anti-ENA) antibodies, Cj, creatinine
clearance, and 24-hour urine protein excretion. The worst values recorded in a particular patient were established.

ANA testing
The immunofluorescent human spleen imprint technique was
used (1,2,4,18). Touch imprints of surgically obtained spleens
were employed as nuclear substrate to detect ANAs by indirect
immunofluorescence using commercially obtained fluorescein
conjugated goat, antihuman gamma globulin (Baltimore
Biological Laboratories, Baltimore, MD). The slides were
examined without cover slips on a fluorescent microscope
(Leitz Ortholux) with a 95X fluorite oil immersion lens and lOX

ANA Pattems in SLE Nephritis—Akbar et al

oculars (1,2). All positive tests (other than weak homogeneous)
were read by at least two observers, usually without knowledge
ofthe patients' clinical status. Patients were grouped according
to their most significant ANA pattem ever shown (4) (Table 2).
This was classified as their "main" pattem. The degree of significance from most to least, based on previously defined
clinical correlations regarding the likelihood of kidney involvement (4), was as follows: shmnken peripheral general, shrunken
peripheral LSANA, peripheral general, peripheral LSANA,
homogeneous general titer 160 or greater, homogeneous
LSANA titer 640 or greater, threads, large speckle-like threads,
and small speckle-like threads (Fig 1). Patients were classified as
demonstrating threads, large and small speckle-like threads as
their main pattem, only when unaccompanied by the peripheral
or significantlytiteredhomogeneous general (160 or greater) or
homogeneous LSANA (640 or greater) pattems.
Testing for anti-DNA and anti-ENA antibodies
Antisingle-stranded DNA antibody determinations were
performed serially using a solid phase radioimmunoassay
technique as described previously (19). Only IgG antisinglestranded DNA antibody results were used in our study. AntiENA antibody assays were performed similarly to the method of
Nakamura et al (20).
Renal function tests
Each patient's creatinine clearance, semm Cj concentrations,
and 24-hour urine protein excretion were measured at the start
of the study and when the disease was in remission or
had stabilized.
Renal biopsies
Renal biopsies were performed before starting treatment in 63
patients. All biopsies were reviewed by one of us who had no
knowledge of the patients' clinical information. The modified
Worid Health Organizafion (WHO) classificafion (21) was used:
Class I: normal by light microscopy (NL).
Class II: mesangial nephrifis (MES).
Class III: focal segmental glomerulonephritis (FSPGN).
Class IV: diffuse proliferafive glomerulonephrifis (DPGN).
Class V: diffuse membranous glomemlonephrifis (MGN).
Glomerular activity was estimated based on the presence and
extent of cellular proliferation, segmental necrosis, wire loop
lesions, hyahne thrombi, and cellular andfibrocellularcrescents
and was assigned a grade on a scale of 0 to 10. The presence and
degree of glomerular sclerosis was interpreted as evidence of
chronic glomemlar injury and was also assigned a grade on a
scale of 0 to 10. A morphologic index (numericafly represenring
the morphologic assessment of the biopsy) was obtained for
each pafient by multiplying the numerical values of glomerular
activity and glomerular sclerosis in each histopathological
class.
Statistical analysis
Student's t test and analysis of multiple variance (ANOVA)
were used to examine statistical significance.
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Table 2
Patients' ANA Profiles
Main Patterns
(No. of Patients)
ShPGen(17)
5
3
1
1
1
1
2
1
1
I
ShP LSANA (1)
P LSANA (10)
3

".^
2
P Gen (18)
3
1
1
4

:

3
2
2
H Gen (11)
4
2
5
T(13)
8
5
SET Lg (3)
3

Nonparticulate System
General, LSANA
Sh P LSANA
Sh P LSANA
Sh P LSANA
P LSANA
P LSANA
H LSANA*
H LSANAt

Particulate
System

SLTLg
OP
T
T

—
—

—
—
—

T
SLTLg
OP

PGen

—

H Gent
H Gent
H Gen§

—
—

P LSANA
P LSANA
P LSANA

—

T

T
SLTLg
OP
T

H Gen§

—
—
—
—

H LSANAt
H Gent
HGen§

—
—
—

H Gen§

—

—

—

P LSANA
H LSANA*

H Gent

Sh P Gen: Shrunken peripheral general ANA.
Sh P LSANA: Shrunken peripheral leukocyte-specific ANA.
P LSANA: Peripheral leukocyte-specific ANA.
H LSANA: Homogeneous leukocyte-specific ANA.
PGen: Peripheral general ANA.
H Gen: Homogeneous general ANA.
T: Thready ANA.
SLT Lg: Large speckle-like thready ANA.
OP: Other particulates.
*Significant titer 640 or greater
tNonsignificant titer less than 640.
tSignificant riter 160 or greater
§Nonsignificant titer less than 160.

Results
Renal function tests and histopathology
Mean creatinine clearances, C, values, and 24-hour proteinuria
results in the different groups are shown in Table 3. Analysis ofthe
renal biopsies is shown in Table 4. The distribution in renal histopathology seen in this group of 63 patients was as follows: MES, 6
patients (9.5%); FSPGN, 11 patients (17.5%); DPGN, 31 patients
(49.2%); and MGN, 15 patients (23.8%).

Anti-DNA and anti-ENA values
The results of the IgG antisingle-stranded DNA antibodies
and anti-ENA (Smith) antibodies are shown in Tables 3 and 5.
Only patients with the homogeneous general pattem with a titer
of 160 or greater in the nonparticulate group had low levels of
anti-DNA antibodies (Table 3). The group of patients with
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(Tables 2, 3, and 5). The concomitant presence of threads in
some patients with the peripheral pattems was probably responsible for the high incidence of positive anti-ENA (Sm) antibody
tests in this group (Tables 3 and 5). These patients also had high
levels of anti-DNA antibodies (Table 4).

threads had lower levels of the anti-DNA antibodies (Tables 3
and 5). All nine of the nine patients with threads that were tested
were anti-ENA (Sm) antibody positive (Table 3). Also, ten ofthe
11 patients from the threads plus significant nonparticulate ANA
pattems that were tested were anti-ENA (Sm) antibody positive

Table 3
Means of the Most Abnormal Serological and Biochemical Values Recorded in Patients
with Different ANA Patterns
ANA
Pattem

Number of
Patients

Sh P Gen
PGen
HGen
P LSANA
T

Ccr

17
IS
1 1
1 1
13

58.2
44.7
45.0
49.9
85.0

± 7.1
± 5.2
± 6 9
± 10.5
± 4.2

79.3
69.5
98.2
73.7
114.9

10.9
9.0
12.1
12.3
10.3

Proteinuria

Anti-DNA (Pts Pos)

2M
4.6
4.4
3.6
4.2

13,2
13.4
3.5
10.4
2.4

-t-

-.±
F-

1.0
2.1
1.4
0.9
2.4

Sh P Gen: Shrunken peripheral general ANA.
P Gen: Peripheral general ANA.
H Gen: Homogeneous general ANA.
P LSANA: Peripheral leukocyte-specific ANA.
T: Thready ANA.
Ccr: Creatinine clearance in mL/min.
C,: Complement-3 levels in U/dL (normal 80 to 200 U/dL).
Proteinuria: Urinary protein in g/24 hr.
Anti-DNA: IgG antisingle-stranded DNA antibodies in jjig/mL. positive 6.9 ^JLg/mL.
Anti-ENA: Anti-ENA (Smith) antibodies in fjLg/mL. positive 7.4 ixg/mL.
Pts Pos: Number of patients positive oul of number of patients tested.
Note: Mean values are recorded ± standard error of mean.

±

2.4
2.4
3.5
3,3
1.0

14 4)
(7/10)
(0/6)
(4/7)
(0/9)

•

Anti-ENA (Sm) (Pts Pos)
0.0
11.0
7.5 -F 1,6
2.7 ± 1,5
8.3 ± 1.5
9,3
0.6

(4/4)
(7/10)
(1/6)
(5/7)
(9/9)

Table 4
Analysis of Renal Biopsies According to ANA Patterns
ANA Pattem
(Number of Patients)

Histopathologic
Classification
(Nuniber of Patients)

ShPGen(13)

PGen (17)

P LSANA (11)

H Gen (9)

T(13)

T plus other
nonparticulates (13)

MES (1)
MGN (0)
FSPGN (4)
DPGN (8)
MES (2)
M G N (1)
F.SI'dN I4i
DPGN (10)
MES (0)
M G N (2)
FSPGN (2)
DPGN (7)
MES (0)
MGN (3)
FSPGN (1)
DPGN (5)
MES (3)
MGN (9)
FSPGN (0)
DPGN(I)
MES (0)
MGN (0)
FSPGN (4)
DPGN (9)

Mean
Glomemlar
Aciivity

Mean Chronic
Glomerular Injury
and Sclerosis

Mean Patient
Morphologic
Indices

3.2

34

53.0

3.4

3.4

41.9

3.0

2.5

48.6

4.0

5,1)

82.6

1.4

2.0

11.3

3.4

3.1

48.1

Sh P Gen: Shrunken peripheral general ANA,
P Gen: Peripheral general ANA,
P LSANA: Peripheral leukcKyte-specific ANA.
H Gen: Homogeneous general ANA,
T: Thready ANA,
T plus other nonparticulates: Thready ANA plus various nonparticulate pattems,
MES: Mesangial glomerulonephritis,
MGN: Membranous glomemloncphritis.
FSPGN; Focal segmental proliferative glomerulonephritis.
DPGN: Diffuse proliferative glomerulonephritis.
Number of renal biopsies; 63. Classification: Class I: Nonnal (0 patients 10%]). Class II: Mesangial GN (6 |9..'i7c|). Class 111; FiKal PGN (11117.5%!),
Class IV; Diffuse GN (31 |49.2%]), Class V; Membranous GN (15 |23%1).

124

Henry Ford Hosp Med J—Vol 36, No 2, 1988

ANA Patterns in SLE Nephritis—Akbar et al

Specific ANA Patterns
Shrunken peripheral general and peripheral general
(35 patients)
In those patients with the shrunken peripheral and peripheral
general patterns, the majority also had other patierns present
(Table 2) (Fig lA and IB). The homogeneous general and
homogeneous LSANA patterns always coexisted with the
shrunken peripheral and peripheral general and LSANA pattems, respectively, either undiluted or on dilufion (1).
Of the 30 patients in these groups who had renal biopsies, 26
were found to have FSPGN or DPGN (Table 4). Patients in these
groups generally had the more severe and active forms of the
disease, which was evident from the higher levels of anfi-DNA
antibody titers and lower C, levels (Table 3). Analysis of renal
biopsies showed a higher level of acfivity and greater proliferative changes (25/30) (Table 4). However, these patients responded well to appropriate therapy accompanied by changes in
these nonparticulate ANA pattems (Figs 2 through 6).

LSANA group (11 patients)
This group included one patient with shrunken peripheral
LSANA and ten patients with peripheral LSANA (Table 2) (Fig
IC). The mean creatinine clearance, C, levels, and 24-hour protein excrefion were in the same range as in those pafients with
shmnken peripheral and peripheral general pattems (Table 3).
Anti-DNA antibody concentrations tended to be lower. Histopathology examination revealed that nine of 11 patients had a
proliferative glomerulonephritis. All patients had renal biopsies. The distribufion of diagnosis is shown in Table 4. The
glomerular activity and sclerosis as shown by the morphologic
indices were comparable to the peripheral general group (Table
4). The clinical course of a patient with peripheral LSANA who
had a marked increase in both creatinine clearance and C, levels
after treatment with nitrogen mustard is depicted in Fig 2.

Homogeneous general ANA group (11 patients)
Only homogeneous pattems with titers of 160 or greater were
considered to be significant (1) (Fig ID). These pafients
had lower mean anti-DNA antibody levels (3.47 pg/mL) and
near-normal C, levels (98.2 U/dL) (Table 3). Nine patients had
renal biopsies. Analysis of renal biopsies showed that these patients had the highest amount of sclerosis or signs of chronic
glomemlar injury. The overall histopathologic picture was more
advanced (morphologic index 82.6) as compared to patients
with the peripheral pattems. These patients also showed an increased propensity to proliferative lesions (6/9) (Table 4).

Table 5
Comparison of Means of the Most Abnormal Serologic and
Biochemical Results Recorded in Patients with Threads and
in Patients with Threads Plus Other ANA Patterns
Ccr
C3

Proteinuria
Anti-DNA
Anti-ENA (Sm)
Ml

Threads
85.0 ± 4.2
114.9 ± 10.3
4.2 ± 2.4
2.4 ± 1.0
9.3 ± 0.6
II.3 ± 4.5

Threads Plus
50.0
60.3 ±
3.2 13.4
10.3 ±
48.1 ±
-i

Others
9.0
11.0
0.7
2.5
0,5

9.1

P Value
0.001
O.OI
NS
O.OI
NS
0.01

Ccr; Creatinine clearance in mL/min.
C,; Complement-3 level in U/dL.
Proteinuria; Urinary protein in g/24 hr
Anfi-DNA: IgG antisingle-stranded DNA antibodies in p,g/mL.
Anfi-ENA (Sm); Anti-ENA (Smith) anribodies in |ji,g/mL,
MI; Morphologic index.
Note; Mean values are recorded ± standard error of mean.
Sec Tabie 3 for nomial values of C, and for positive values of anti-DNA and anti-ENA.

Clinical
Signs a
Symptoms

Jt. Pain [Fever
Poncylo 'Jt. Pain
penia
Facial
Rosti

IFever IHigh Blood
'Joint ' Pressure
Pain Edenna
Wt. Loss

ISympto
' Free

u -Llndiluted Positive
0-Small Speckle-Like Threads
A-Leucocyte Specific Homogenous ANA
X-General Homogenous ANA
p - Peripheral

Nitrogen
Mustard
Imuran

(mg)

Threads (13 patients)
These pafients had the highest mean creatinine clearance
(85.0 mL/min) (Fig IE). They also showed less acfivity and severity of the disease as evidenced by low anti-DNA antibody
levels (2.37 pg/mL) and high C, levels (115.0 U/dL). All these
values were statistically significantly better than corresponding
values for other groups of patients (Tables 3 and 5).
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Prednisone
(mg)

9,19. Ij, 12/
'74 74

(•4

Fig 2—Correlations of clinical and laboratory findings.
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Clinical
Signs a
Symptoms

20480

Fever
Joint Pain
Molar Rosh

Malar
Rosh
Pregnancy
I

^ShP

Symptom
Anasarca
Anasarca
Free
Jl. Pain
Leukopenia
Pregnancy Pneumonia
I
Varicella
intracronial
Bleeding
Rt. Hemi
Paresis
I
Craniotomy

Clinical
Signs a
Symptoms

20480
5120
1280
ANA

320
80
20

u - U n d i l u i e d Posilive Only
X - General Homogenous ANA
6 - Leucocyte Specific Homogenous ANA
P - Peripheral
S h P - S h r u n i i e n Peripheral

0

X -General Homogenous ANA
- L e u c o c y t e Specific Homogenous ANA
P - Penpherol
ShP-Shrunken Peripheral

1-4

Fig 4—Correlations of clinical and laboratory findings.

Fig 3—Correlations of clinical and laboratory findings.
A high incidence of the benign forms of histopathology (12 of
13 patients; MES, 3 patients, and MGN, 9 patients [Table 4])
was present in this group. Also, the activity or acute glomemlar
injury and the morphologic index were significantly lower (P <
0.002) than in other groups. These results clearly indicate less
severe disease in patients with the thready pattem.
Thirteen patients had threads associated with significant nonparticulate ANA pattems (Table 2). These patients did not show
any significant differences in the activity or severity of disease
(Table 5) as compared to their counterparts in the nonparticulate
pattem group without threads.
Large speckle-like threads
One patient had a FSGN and another MGN, but their biopsies
were not fully analyzed and therefore not included in the tables.
No conclusions can be made because of the small number of
patients in this group. As discussed, patients with large specklelike threads as their main pattern usually do not have renal
involvement.
Changes in ANA patterns and titers with therapy
A fall in titer occurred in both the peripheral homogeneous
and the particulate systems with therapy. However, two differences were noted in the behavior of the systems;
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1. The mean titer ofthe peripheral homogeneous system was
lower than that of the particulate system. Using the highest titers
ever recorded in each patient, the mean homogeneous general ANA
titer was 1,650 (40 to 10,240). These results included all patients in
the peripheral homogeneous groups with or without concomitant
particulate pattems. The mean highest titer of the patients with
LSANA was 4,406 (40 to 20,480). In the particulate pattems the
mean highest titer of the thready pattem was 70,976 (640 to
163,840), 13,344 (160 to 40,960) for large speckle-like threads, but
only 322 (5 to 640) for small speckle-like threads.
2. The peripheral homogeneous system, both general and
LSANA, was sensitive to therapy and to changes in disease
activity in that with immunosuppressive therapy the peripheral
patterns disappeared, leaving only the homogeneous patterns
which in tum also could disappear (Figs 2 and 3). A common
evolution, similar to that seen with serum dilution (1), was from
shrunken peripheral to peripheral to homogeneous with progressive reduction in the titer of the homogeneous pattems when
the disease became less active (Fig 4). Titers reported were those
of the homogeneous patterns to which the peripheral patterns
had converted. Conversely, particulate pattems such as threads
tended to persist, although a fall in titers usually occurred (Figs
2 and 5). The only particulate pattems which disappeared were
the small speckle-like threads in one patient, while two patients
lost patterns in the "other particulates" group (Table 1). With
reactivation of SLE, the reverse of this process was seen in the
peripheral homogeneous system in that the general peripheral
(Fig 5) and both the general peripheral and the LSANA pe-
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Clinical
Signs and
Symptoms

Infiltrate
RLL — • C l e a r e d
Ulcer Rt, Medial Malleolus

Fever
Jt, Pom
Weakness

163840
SI920
40960
I0Z40
5120

I2S0

ANA

f"

24hr
Urine
Protein
(gms)

Cc,

Imuran
(mgs)
Prednisone
(mgs)

Fig 5—Correlations of clinical and laboratory findings.

ripheral pattems (Fig 6) reappeared (Figs 2, 5, and 6). In one
patient the shmnken peripheral LSANA pattem appeared with a
relapse (Fig 4). Reappearance of the general peripheral pattem
was accompanied in one patient by elevation in the titer of
the thready pattem (Fig 5). No significant changes occurred in
ANA patterns and titers 10 minutes after intravenous injection
of nitrogen mustard (Figs 2, 3, 4, and 6). IgG anti-DNA
antibody concentrations were also noted to decrease from
12 Pg/mL or greater to 4 pg/mL or less with improvement in the
patients' condition.

Discussion
The various nuclear immunofluorescent pattems are associated with antinuclear antibodies which react with different
nuclear antigens (18). The diagnostic and prognostic aspects of
these patterns and titers can be appreciated only by accurate
morphologic classification (1,4). Of equal importance in analyzing the relationship of ANA titer changes to changes in clinical
status and treatment is that differentiation must be made between
the two main ANA pattern systems: the peripheral homogeneous system and the particulate group as described earlier.
Futhermore, the type of nuclear substrate and the technique
employed affect the sensitivity of the ANA test using immunofluorescence (1). We have found that human spleen imprints
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have considerable advantages over other nuclear substrates
regarding both sensitivity and ease with which the different
pattems can be idenfified (1,2,4). If a less sensitive substrate is
employed and if, in addition, accurate morphologic pattern
identification is not pracficed, the different nuclear immunofluorescent pattems cannot be distinguished from each other.
This may explain why some authors' findings (16,17,22) have
differed from ours (1,2,4). However, Nisengard et al (23) did
find that the combination of the peripheral pattem accompanied
by atiterof 160 or greater correlated with active disease in SLE.
We have demonstrated that there is indeed a close correlation of
ANA pattems with specific connective tissue diseases (1) and
specifically of pattems and titers with activity and severity of
SLE (4), especially when thetitersof the two main ANA pattem
systems are considered separately as in this study. An extreme
example of the need to discriminate between the two ANA pattem systems in regard to titers is shown in Fig 5. Had such a
differentiation not been made in this patient, an erroneous judgment of reactivation of the disease would have been reached even
though the patient was in a clinical remission. In fact, the homogeneous titer had fallen to 40, correlating well with clinical
improvement, whereas the thready titer was still 10,240.
In this report we have attempted to correlate ANA patterns
and titers found before therapy with subsequent exacerbation or
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improvement of the disease and the effect of the treatment. The
shrunken peripheral general pattern can be seen early in SLE
with active kidney involvement and is associated with high IgG
anti-DNA antibody levels. This pattem is seen mainly in early or
active forms of the disease and usually disappears with therapy.
Even though the shmnken peripheral general pattem has been
considered to be of poor prognostic significance, in the sense of
its close association with renal involvement (4), it will confirm
the diagnosis of SLE with presumptive renal disease at an early
phase as shown by moderate changes in renal function and histopathology before irreversible damage has occurred (Figs 3,4,
and 6).
Patients with the thready ANA pattem as their main pattem
seem to have a less severe form of SLE nephritis. This is reflected by the significantiy better results of this group of patients
(Tables 3, 4, and 5) as compared to all other groups of patients.
We have found that the nuclear antigen with which the thready
pattem reacts appears to be a large complex of protein and RNA
which is associated with the nuclear membrane (24).
Clinicopathologic studies using the WHO classification have
established that classes II and V (mesangial glomerulonephritis and membranous glomemloncphritis) have a much better
prognosis (85% to 90%five-yearrenal function survival) than
classes III and IV (FSPGN and DPGN) (60%five-yearrenal
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function survival). Thus, these results which show that 12 (92%)
of 13 patients with threads had class II and V types of renal involvement are clearly of significance. Of the other 50 patients
with renal biopsies (ANA pattems different than threads), only
nine patients (18%) had class II and V disease; 41 patients (82%)
showed proliferative glomerulonephritis (FSPGN and DPGN).
The relative frequency of the different forms of histopathology
seen in our group of patients was similar to the results of five
series comprising over 300 patients that used the same WHO
classification (25).
When the degree of activity and chronicity or sclerosis in the
renal biopsies were quantitatively compared between patients
with threads and those with other pattems, again a striking difference was noted. The renal biopsies of patients with threads
showed much less glomerular activity, sclerosis, and a lower
morphologic index when compared to the other group of
patients (Table 4).
However, when patients have significant nonparticulate pattems along with the thready pattem, the benign implications of
the thready pattem as the main pattera are no longer present. We
found that all 13 such patients had a proliferative lesion (FSPGN
and DPGN) on renal biopsy. The degree ofactivity and sclerosis
was greater and the total morphology was worse than in those
with the thready pattem only as evidenced by the morphologic
index (Table 4).
Sharp et al (26) reported that 86% of patients with SLE
nephritis who responded to therapy had antibodies to ENA,
while only 8% of the patients with SLE nephritis who did not
respond to therapy had anti-ENA antibodies. Sharp et al (27)
suggested that anti-ENA antibodies might have a protective
effect in patients with SLE. It has been postulated that anti-ENA
antibodies are associated with the thready pattems seen with the
fluorescent antibody technique (28). The thready pattern was
found to have the highest correlation of anti-Sm antibodies
(90%) compared to any other group (5). In our study this higher
correlation was again noted in the threads plus other nonparticulate pattems group (Tables 2,3, and 5) and was also found in the
patients with only threads (Table 3). That patients with the
thready pattem as their main pattern have less severe renal disease than patients with other patterns and that mesangial and
membranous glomemlopathy are the types of renal involvement
more commonly found in this group suggests that these patients
may represent a different subset of renal SLE. The thready pattern is thus an immunologic marker for this narrow clinical subset of renal SLE. Thefindingsof Winn et al (29), in which SLE
patients with antibody to Sm antigen (frequently associated with
the thready pattem) had a more benign form of renal disease,
are intriguingly similar to ours. Sharp et al (26) reported that
renal disease was associated with antidouble-stranded DNA
antibodies. We found that patterns associated with high or
intermediate IgG antisingle-stranded DNA antibody levels
(shmnken peripheral and peripheral) also are among those that
may frequently be associated with renal involvement.
Although long-term immunosuppressive therapy with
clinical improvement was accompanied by changes in the peripheral homogeneous system, intravenous nitrogen mustard
had no immediate effect on ANAtiters(Figs 2,3,4, and 6), and
results of immediate subsequent specimens are therefore valid
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for evaluation of the clinical status. Possible reasons why the homogeneous pattem group (rather than the peripheral group) had
greater degrees of sclerosis with the highest morphologic indices (Table 4) are: 1) since five patients had already been treated
at the time oftheirfirstANA specimen, they might have demonstrated the peripheral pattems prior to immunosuppressive therapy; and/or 2) they had received suboptimal immunosuppressive
therapy early in their disease which nevertheless continued to
progress slowly (Table 4). Improvement in the clinical status
sometimes could have been predicted, based on the fall in titer in
the peripheral homogeneous system (Figs 2, 4, 5, and 6). In a
few patients the reverse could be observed, in that a pattem or
titer higher in the peripheral homogeneous system reappeared in
association with a relapse of the disease (Figs 2, 4, 5, and 6).
We wish to reemphasize that in the evaluation of titers it is
important to determine the titers of each of the main pattem systems separately because the titers of the particulate pattems tend
to be higher than those of the nonparticulate peripheral homogeneous system. Failure to make such a differentiation may
explain the lack of correlation betweentitersand clinical presentation as found by most other authors.
Our results demonstrate that autoantibody profiles comprised
of ANA immunofluorescent pattems and titers along with IgG
antisingle-stranded DNA antibodies and to a lesser extent antiENA antibodies are useful in the evaluation of patients suspected of having SLE. Not only can the diagnosis of SLE
be confirmed eariy, but prognostic data can also be obtained
regarding the likelihood and severity of renal disease. Furthermore, therapeutic guidelines are available as shown by changes
in patterns and titers in the peripheral homogeneous system.
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